Literature DB >> 16797939

Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma.

Jeremy D Coplan1, Sanjay J Mathew, Xiangling Mao, Eric L P Smith, Patrick R Hof, Paul M Coplan, Leonard A Rosenblum, Jack M Gorman, Dikoma C Shungu.   

Abstract

We have demonstrated, using proton magnetic resonance spectroscopy imaging ((1)H-MRSI), elevations of N-acetyl-aspartate/creatine (NAA/CR) in right dorsolateral prefrontal cortex (DLPFC) in patients with generalized anxiety disorder (GAD) in comparison to healthy volunteers. A recent study indicates that the volume of prefrontal cortical white matter may be disproportionately increased in man in comparison to other primate species, with evolutionary implications. We therefore re-analyzed the identical scans with a specific focus on the centrum semiovale (CSO) as a representative region of interest of cerebral white matter. The central hypothesis was, in accordance with our gray matter findings, that patients with GAD, in comparison to healthy controls, would exhibit either an increase in NAA in CSO, or alternatively demonstrate reductions in concentrations of choline (CHO)-containing compounds and/or creatine+phosphocreatine (CR). MRSI scans that were obtained from an earlier [Mathew, S.J., Mao, X., Coplan, J.D., Smith, E.L., Sackeim, H.A., Gorman, J.M., Shungu, D.C., 2004. Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study. American Journal of Psychiatry 161, 1119-1121] sample of 15 patients with GAD [6 with early trauma (ET)] and 15 healthy age- and sex-matched volunteers were analyzed further for CSO metabolite alterations. Self-reported worry was scored using the Penn State Worry Questionnaire (PSWQ) and intelligence was assessed using the Wechsler Abbreviated Scale of Intelligence (WASI). Serial multislice/multivoxel MRSI scans had been performed on a 1.5-T MRI. Using absolute quantification methods for metabolite concentrations, we examined NAA, CHO and CR. GAD patients without ET exhibited bilaterally decreased concentrations of CHO and CR in CSO in comparison to healthy volunteers, whereas GAD patients with ET were indistinguishable from controls. In patients with GAD, high IQ was paired with greater worry, whereas in healthy volunteers, high IQ was associated with less worry. In all subjects, IQ inversely predicted left and right CSO CHO concentrations, independent of age, sex, group assignment and PSWQ scores. The CSO may therefore represent a neural substrate that exhibits reductions in CHO and CR metabolite concentrations that are inversely associated with GAD symptomatology and, in the case of CHO, with intelligence. These conclusions are deemed preliminary due to small sample size, with further study of cerebral WM in anxiety disorders suggested.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797939     DOI: 10.1016/j.pscychresns.2005.12.011

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  15 in total

1.  Acute restraint-mediated increases in glutamate levels in the rat brain: an in vivo ¹H-MRS study at 4.7 T.

Authors:  Sang-Young Kim; Eun-Ju Jang; Kwan Su Hong; Chulhyun Lee; Do-Wan Lee; Chi-Bong Choi; Hyunseung Lee; Bo-Young Choe
Journal:  Neurochem Res       Date:  2011-12-22       Impact factor: 3.996

Review 2.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

3.  Pilot multimodal twin imaging study of generalized anxiety disorder.

Authors:  John M Hettema; Birgit Kettenmann; Vishwadeep Ahluwalia; Christopher McCarthy; Wendy R Kates; James E Schmitt; Judy L Silberg; Michael C Neale; Kenneth S Kendler; Panos Fatouros
Journal:  Depress Anxiety       Date:  2011-10-12       Impact factor: 6.505

4.  Early-life stress and neurometabolites of the hippocampus.

Authors:  Jeremy D Coplan; Sanjay J Mathew; Chadi G Abdallah; Xiangling Mao; John G Kral; Eric L P Smith; Leonard A Rosenblum; Tarique D Perera; Andrew J Dwork; Patrick R Hof; Jack M Gorman; Dikoma C Shungu
Journal:  Brain Res       Date:  2010-08-14       Impact factor: 3.252

5.  Rare copy number deletions predict individual variation in human brain metabolite concentrations in individuals with alcohol use disorders.

Authors:  Ronald A Yeo; Steven W Gangestad; Charles Gasparovic; Jingyu Liu; Vince D Calhoun; Robert J Thoma; Andrew R Mayer; Ravi Kalyanam; Kent E Hutchison
Journal:  Biol Psychiatry       Date:  2011-09-15       Impact factor: 13.382

6.  Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.

Authors:  Sanjay J Mathew; Rebecca B Price; Xiangling Mao; Eric L P Smith; Jeremy D Coplan; Dennis S Charney; Dikoma C Shungu
Journal:  Biol Psychiatry       Date:  2007-10-29       Impact factor: 13.382

7.  The Relationship between Intelligence and Anxiety: An Association with Subcortical White Matter Metabolism.

Authors:  Jeremy D Coplan; Sarah Hodulik; Sanjay J Mathew; Xiangling Mao; Patrick R Hof; Jack M Gorman; Dikoma C Shungu
Journal:  Front Evol Neurosci       Date:  2012-02-01

8.  Anxiety and depression in patients with breast cancer undergoing radiotherapy: the role of intelligence, life history, and social support-preliminary results from a monocentric analysis.

Authors:  Marc D Piroth; Silvia Draia; Jehad Abu Jawad; Martina Piefke
Journal:  Strahlenther Onkol       Date:  2022-03-03       Impact factor: 3.621

9.  Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight.

Authors:  Jeremy D Coplan; Hassan M Fathy; Chadi G Abdallah; Sherif A Ragab; John G Kral; Xiangling Mao; Dikoma C Shungu; Sanjay J Mathew
Journal:  Neuroimage Clin       Date:  2014-01-09       Impact factor: 4.881

10.  Quantitative 3.0T MR spectroscopy reveals decreased creatine concentration in the dorsolateral prefrontal cortex of patients with social anxiety disorder.

Authors:  Qiang Yue; Mengqi Liu; Xiaojing Nie; Qizhu Wu; Jun Li; Wei Zhang; Xiaoqi Huang; Qiyong Gong
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.